In the Kaplan–Meier graph, an increased breast cancer-specific mortality was observed in the group with low compared to high THRα-2 expression, up until 18 years of follow-up, at which point the two curves converged (Fig. 3a, log-rank p = 0.08). This evidence concerns the gene THRA and breast carcinoma.